@article{a30120c2b7554a59a2aa85ec95107fd7,
title = "Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents",
keywords = "Anti-cancer agents, quinoline derivatives, marketed drugs, clinical trials, molecular targets, major mechanisms, TYROSINE KINASE INHIBITOR, TOPOISOMERASE-I INHIBITOR, DUAL PI3K/MTOR INHIBITOR, GROWTH-FACTOR, DNA TOPOISOMERASES, HEPATOCELLULAR-CARCINOMA, LIPOSOMAL FORMULATION, MOLECULAR-MECHANISMS, SELECTIVE ACTIVATION, CAMPTOTHECIN ANALOG, Major mechanisms, Clinical trials, Quinoline derivatives, Marketed drugs, Molecular targets",
author = "Ruo-Jun Man and Nasreen Jeelani and Chongchen Zhou and Yu-Shun Yang",
note = "Publisher Copyright: {\textcopyright} 2021 Bentham Science Publishers.",
year = "2021",
doi = "10.2174/1871520620666200516150345",
language = "English",
volume = "21",
pages = "825--838",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "BENTHAM SCIENCE PUBL LTD",
number = "7",
}
